Ticar, Darel D.

HRN: 27-53-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2025
CEFUROXIME 750MG (VIAL)
07/24/2025
07/31/2025
IV
750mg
Q 8 Hours
Intestinal Amoebiasis; T/C UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines